|
|
|
|
|
|
Refocused Reagent-Based Strategy: Health Advances worked with a client on a strategic repositioning to exploit high growth segments of the biomedical
research market. We explored the application of new technologies in genomics and proteomics segments, opportunities in instruments, reagents, and kits. This resulted
in a completely new focus for the company and led to a significant joint venture with an industry leader.
Microarray Strategy: A multinational corporation with a novel technology for microarray production enlisted Health Advances to evaluate the opportunity
for its technology, determine an appropriate positioning in the marketplace, define key performance parameters, and develop an entry stra
tegy using a combination of
collaborative partnerships to accelerate market penetration.
High Throughput Screening: Health Advances assisted a client with the spinout of a new company from an established company to develop and market a new
instrument for high throughput screening of chemical libraries. The novel technology uses whole cell assays in multi-well plates and a proprietary detection medium.
The new instrument is likely to compete effectively in the market, potentially replacing fluorescence-based assays.
Consumables Penetration Strategy: A client engaged Health Advances to assist in developing a market penetration strategy in microarrays based on a new
approach for utilizing clinical samples for drug discovery. Exploiting the shift to systems-based biology, our client better understood how to drive growth through
customer segmentation, product positioning, and target marketing within large pharmaceutical research organizations.
Whole Genome Amplification for Large Scale SNP Analysis: A client sought assistance from Health Advances in developing a distribution and pricing strategy
for penetrating large pharmaceutical companies with a novel drug discovery technology. The Health Advances team performed an extensive examination of successful examples
of industry leading distribution models and product launch strategies, including a comprehensive review of DNA amplification technologies and products.
|
|
 |
|
|
|
|
